Kymera Therapeutics (KYMR) PT Raised to $140 at Mizuho

July 16, 2026 5:29 AM

Mizuho analyst Joseph Catanzaro raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $140.00 (from $120.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found